Julen
Oyarzabal Santamarina
Chercheur jusqu' 2018
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (4)
2019
-
Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease
Molecular Neurobiology, Vol. 56, Núm. 8, pp. 5900-5910
2016
-
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease
Brain, Behavior, and Immunity, Vol. 57, pp. 94-105
2014
-
Phosphodiesterase inhibition in cognitive decline
Journal of Alzheimer's Disease, Vol. 42, pp. S561-S573
2013
-
Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD
Neuropharmacology, Vol. 64, pp. 114-123